These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 25746966

  • 21. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S, Terada M, Hozawa M.
    Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
    [Abstract] [Full Text] [Related]

  • 22. [Administration of budesonide (inhaled steroid) to children to control intermittent asthma].
    Ponce Castro H, Rodríguez Espino S, Rodríguez Orozco AR.
    Rev Alerg Mex; 2009 Apr; 56(1):9-12. PubMed ID: 19374158
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM, Gotfried MH, Lawrence D, Lassen C, Kramer B.
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [Abstract] [Full Text] [Related]

  • 24. [Corticosteroid treatment in airways narrowing].
    Chazan R.
    Pneumonol Alergol Pol; 2008 Dec; 76(2):96-100. PubMed ID: 18464224
    [Abstract] [Full Text] [Related]

  • 25. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 26. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
    Martinez FJ, Calverley PM, Goehring UM, Brose M, Fabbri LM, Rabe KF.
    Lancet; 2015 Mar 07; 385(9971):857-66. PubMed ID: 25684586
    [Abstract] [Full Text] [Related]

  • 27. Consensus document on the overlap phenotype COPD-asthma in COPD.
    Soler-Cataluña JJ, Cosío B, Izquierdo JL, López-Campos JL, Marín JM, Agüero R, Baloira A, Carrizo S, Esteban C, Galdiz JB, González MC, Miravitlles M, Monsó E, Montemayor T, Morera J, Ortega F, Peces-Barba G, Puente L, Rodríguez JM, Sala E, Sauleda J, Soriano JB, Viejo JL.
    Arch Bronconeumol; 2012 Sep 07; 48(9):331-7. PubMed ID: 22341911
    [Abstract] [Full Text] [Related]

  • 28. Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome.
    Rhee CK.
    Korean J Intern Med; 2015 Jul 07; 30(4):443-9. PubMed ID: 26161009
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP.
    Lancet Respir Med; 2013 Nov 07; 1(9):714-27. PubMed ID: 24429275
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study.
    Sinojia R, Shaikh M, Kodgule R, Bhosale S, Madas S, Vaidya A, Salvi S, Brashier B.
    Respir Physiol Neurobiol; 2014 Jan 15; 191():52-9. PubMed ID: 24211316
    [Abstract] [Full Text] [Related]

  • 32. Budesonide/formoterol in the treatment of asthma.
    Hodgson D, Mortimer K, Harrison T.
    Expert Rev Respir Med; 2010 Oct 15; 4(5):557-66. PubMed ID: 20923335
    [Abstract] [Full Text] [Related]

  • 33. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.
    Deesomchok A, Webb KA, Forkert L, Lam YM, Ofir D, Jensen D, O'Donnell DE.
    COPD; 2010 Dec 15; 7(6):428-37. PubMed ID: 21166631
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.